Ajanta Pharma has issued a clarification regarding a news item that appeared in various publications concerning a potential stake in Restaurant Brands Asia. The company stated that neither Ajanta Pharma nor its management is involved in any discussions or negotiations regarding the acquisition of any stake in Restaurant Brands Asia or Burger King franchise entity. Ajanta Pharma denies any rumors related to the news.
Response to Media Speculation
Ajanta Pharma has responded to news articles published on January 19, 2026, which suggested a potential investment in Restaurant Brands Asia, the operator of Burger King in India. These reports mentioned that it was unclear what stake Ajanta might acquire.
Official Statement
Ajanta Pharma clarifies that neither the company nor its management is participating in any transaction related to Restaurant Brands Asia. The company explicitly states it has not engaged in any discussions, negotiations, or considerations regarding acquiring a stake in Restaurant Brands Asia or any Burger King franchise.
Rebuttal of Rumors
Ajanta Pharma emphasizes that the reference to the company in the news article is incorrect. They also deny all rumors and speculation circulating in social media regarding this matter. Ajanta Pharma reaffirms its commitment to corporate governance and transparent disclosure practices.
Source: BSE
